What is the treatment for someone suspected of having an opioid overdose using Narcan (naloxone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Suspected Opioid Overdose with Naloxone

For a suspected opioid overdose, immediately activate the emergency response system, provide high-quality CPR (compressions plus ventilation) if the person is unresponsive and not breathing normally, and administer naloxone. 1

Initial Assessment and Response Algorithm

  1. Identify suspected opioid overdose:

    • Unresponsiveness
    • Respiratory depression (slow, shallow, or absent breathing)
    • Pinpoint pupils (miosis) - though this may not always be reliable
    • Evidence of opioid use nearby
  2. Immediate actions:

    • Activate emergency response system (call 911) 1
    • Do not delay emergency activation while waiting for response to naloxone 1
    • Assess breathing and responsiveness
  3. Response based on breathing status:

    • If not breathing or breathing abnormally (gasping):

      • Begin high-quality CPR (compressions plus ventilation) 1
      • Administer naloxone while continuing resuscitation efforts 1
    • If breathing but unresponsive:

      • Place in recovery position
      • Administer naloxone
      • Monitor closely

Naloxone Administration

  • Route of administration: Intranasal or intramuscular routes are both effective 2, 3

    • Higher-concentration intranasal naloxone (2 mg/mL) has similar efficacy to intramuscular naloxone 3
    • Intranasal administration avoids needles and risk of needle-stick injuries 2
  • Dosing: Follow package instructions for specific formulation

    • Repeat doses may be necessary if no response in 2-3 minutes
    • More than 20 studies demonstrate naloxone is safe and effective for treating opioid-induced respiratory depression 1
  • Continue resuscitation: Do not stop CPR while waiting for naloxone to take effect 1

    • Naloxone should not delay components of high-quality CPR 1

Post-Administration Management

  • After return of spontaneous breathing:

    • Continue to monitor the patient closely 1
    • All patients should be observed in a healthcare setting until risk of recurrent opioid toxicity is low 1
    • The patient's level of consciousness and vital signs should normalize before discharge 1
  • Watch for recurrence of overdose:

    • The duration of action of naloxone may be shorter than the respiratory depressive effects of opioids, particularly long-acting formulations 1
    • Repeated doses or an infusion of naloxone may be necessary if opioid toxicity recurs 1
  • Transport to healthcare facility:

    • All patients should be transported to a healthcare facility for observation 1
    • Patients who refuse transport should be evaluated according to local protocols for capacity to refuse care 1

Important Considerations and Pitfalls

  • Safety profile: Naloxone has an excellent safety profile and is unlikely to be harmful if given to a person with respiratory depression who does not have an opioid overdose 1

  • Common pitfalls to avoid:

    • Delaying CPR while waiting for naloxone to take effect
    • Failing to activate emergency services immediately
    • Assuming a single dose of naloxone will be sufficient, especially with long-acting opioids
    • Discharging patients too early after naloxone administration
    • Failing to recognize that naloxone's duration of action may be shorter than the opioid's effects 4
  • Potential adverse effects:

    • Acute withdrawal syndrome (vomiting with risk of aspiration) 4
    • In patients treated for severe pain, high-dose or rapidly infused naloxone may cause catecholamine release leading to pulmonary edema and cardiac arrhythmias 4

By following this algorithm, first responders and healthcare providers can effectively manage suspected opioid overdoses, potentially saving lives while minimizing risks associated with naloxone administration.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intranasal naloxone administration for treatment of opioid overdose.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014

Research

Naloxone treatment in opioid addiction: the risks and benefits.

Expert opinion on drug safety, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.